Physician

Helen Feng, MD

According to 2025 Medicare claims, Helen Feng, MD (NPI: 1629174149) practices rheumatology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is BAY AREA ARTHRITIS CARE, INC., A MEDICAL GROUP (NPI: 1841623733; TIN: 463409440) and primary practice location at 95124-9998.

Feng's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 315 traditional Medicare patients, billed 63,718 HCPCS/CPT codes, and received $964,852 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,977 prescription claims across 280 beneficiaries totaling $1,674,241 in drug costs, led by Xeljanz Xr (Tofacitinib Citrate). 2019 DME data shows 12 claims. Open Payments data shows 211 records totaling $6,021. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,284,728 and ending at $1,674,241. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $808 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$539K$1.1M2015 Medicare payment: $632,883 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $695,752 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $893,504 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $777,380 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,078,108 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,055,086 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,053,767 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $894,905 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $794,169 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $964,852 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201526527,405$632,883
201629031,962$695,752
201734152,044$893,504
201837653,987$777,380
201940484,940$1,078,108
202035687,696$1,055,086
202136285,570$1,053,767
202233266,712$894,905
202330752,042$794,169
202431563,718$964,852

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.1M2015 Drug cost: $1,284,728 (USD; Tot_Drug_Cst)2016 Drug cost: $1,600,352 (USD; Tot_Drug_Cst)2017 Drug cost: $3,116,040 (USD; Tot_Drug_Cst)2018 Drug cost: $1,696,190 (USD; Tot_Drug_Cst)2019 Drug cost: $1,482,517 (USD; Tot_Drug_Cst)2020 Drug cost: $1,354,902 (USD; Tot_Drug_Cst)2021 Drug cost: $1,139,843 (USD; Tot_Drug_Cst)2022 Drug cost: $1,231,980 (USD; Tot_Drug_Cst)2023 Drug cost: $1,575,452 (USD; Tot_Drug_Cst)2024 Drug cost: $1,674,241 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152281,597$1,284,728
20162421,805$1,600,352
20173192,263$3,116,040
20183372,337$1,696,190
20193562,311$1,482,517
20203322,384$1,354,902
20213051,959$1,139,843
20222731,839$1,231,980
20232741,792$1,575,452
20242801,977$1,674,241

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.4K$2.8K2015 Medicare payment: $2,796 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,999 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,411 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151740$2,796
2016N/RN/RN/R
2017N/RN/RN/R
20181217$1,999
2019N/R12$1,411
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more303810$171
99490Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month173855$60
99457Management using the results of remote vital sign monitoring per calendar month, first 20 minutes145502$50
J0897Injection, denosumab, 1 mg14915,424$21
96372Injection of drug or substance under skin or into muscle159419$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Xeljanz XrTofacitinib Citrate291,110$204,582
EnbrelEtanercept23644$169,234
ProliaDenosumab9516,830$164,313
RinvoqUpadacitinib21630$131,657
OrenciaAbatacept/Maltose27714$112,884

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.211$6,021Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Helen Feng, MD?

Tedicare shows public-source Medicare data for Helen Feng, MD (NPI 1629174149), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Helen Feng, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Helen Feng, MD?

Helen Feng, MD is linked to BAY AREA ARTHRITIS CARE, INC., A MEDICAL GROUP (billing NPI 1841623733) in the available physician profile data.

Does Helen Feng, MD have Open Payments data?

Helen Feng, MD has 211 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.